Get started
Author

Byeongjun Yu

Observed names: Yu Byeongjun, 유병준
ORCID: 0000-0002-3539-9416
Observed ORCID: 0000-0002-3539-9416
OpenAlex ID: A5059458215
Multistimuli‐Responsive Bilirubin Nanoparticles for Anticancer Therapy
2016 · Yonghyun Lee, Soyoung Lee, et al. · Angewandte Chemie International Edition · 108
Prevention of Bacterial Colonization on Catheters by a One-Step Coating Process Involving an Antibiofouling Polymer in Water
2017 · Hyeongseop Keum, Jin Yong Kim, et al. · ACS Applied Materials & Interfaces · 98
Ultrasensitive Electrochemical Detection of miRNA-21 Using a Zinc Finger Protein Specific to DNA–RNA Hybrids
2017 · Chiew San Fang, Kwang-sun Kim, et al. · Analytical Chemistry · 74
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse
2020 · Yujin Kim, Sukmo Kang, et al. · Angewandte Chemie International Edition · 61
Solid-phase recombinase polymerase amplification using an extremely low concentration of a solution primer for sensitive electrochemical detection of hepatitis B viral DNA
2021 · Andi Muhammad Ichzan, Sang-Hyun Hwang, et al. · Biosensors and Bioelectronics · 38
Enhanced Electron Transfer Mediated by Conjugated Polyelectrolyte and Its Application to Washing-Free DNA Detection
2018 · Seonhwa Park, Ji-Eun Jeong, et al. · Journal of the American Chemical Society · 23
Electrochemical detection of interleukin-8 in human saliva using a polyenzyme label based on diaphorase and neutravidin
2020 · Aman Bhatia, Hee Sam Na, et al. · Sensors and Actuators B Chemical · 15
Tubulin‐Based Nanotubes as Delivery Platform for Microtubule‐Targeting Agents
2020 · Jinjoo Kim, Juncheol Lee, et al. · Advanced Materials · 14
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse
2020 · Yujin Kim, Sukmo Kang, et al. · Angewandte Chemie · 12
Diaphorase-Catalyzed Formation of a Formazan Precipitate and Its Electrodissolution for Sensitive Affinity Biosensors
2020 · Al-Monsur Jiaul Haque, Ponnusamy Nandhakumar, et al. · Analytical Chemistry · 11
A Hybrid Platform Based on a Bispecific Peptide–Antibody Complex for Targeted Cancer Therapy
2019 · Byeongjun Yu, Dobeen Hwang, et al. · Angewandte Chemie International Edition · 11
Abstract 328: LCB84, a TROP2-targeted ADC, for treatment of solid tumors that express TROP-2 using the hu2G10 tumor-selective anti-TROP2 monoclonal antibody, a proprietary site-directed conjugation technology and plasma-stable tumor-selective linker chemistry
2022 · Hyejung Kim, Emanuela Guerra, et al. · Cancer Research · 10
Multistimuli‐Responsive Bilirubin Nanoparticles for Anticancer Therapy
2016 · Yonghyun Lee, Soyoung Lee, et al. · Angewandte Chemie · 7
Drug‐Delivery Systems: Tubulin‐Based Nanotubes as Delivery Platform for Microtubule‐Targeting Agents (Adv. Mater. 33/2020)
2020 · Jinjoo Kim, Juncheol Lee, et al. · Advanced Materials · 4
Gold nanorods with an ultrathin anti-biofouling siloxane layer for combinatorial anticancer therapy
2020 · Jinjoo Kim, Hyeongseop Keum, et al. · Journal of drug targeting · 4
A Hybrid Platform Based on a Bispecific Peptide–Antibody Complex for Targeted Cancer Therapy
2019 · Byeongjun Yu, Dobeen Hwang, et al. · Angewandte Chemie · 4
Abstract 7209: Status-agnostic therapy of breast cancer using antibodies targeting O-glycosylated proteins
2025 · Aaron C. Groen, Nisha Shrestha, et al. · Cancer Research · 2
Abstract 2613: Treatment of solid tumors with antibody drug conjugates targeting aberrant O-glycoproteins
2024 · Aaron C. Groen, Nisha Shrestha, et al. · Cancer Research · 1
Effective Combination Immunotherapy through Vessel Normalization Using a Cancer‐Targeting Antiangiogenic Peptide–Antibody Hybrid
2022 · Byeongjun Yu, Dohyun Yoo, et al. · Advanced Therapeutics · 1
Abstract 2999: Hybrid complex between bispecific peptide and antibody for targeted cancer therapy
2019 · Byeongjun Yu, Dobeen Hwang, et al. · Experimental and Molecular Therapeutics
Abstract 2999: Hybrid complex between bispecific peptide and antibody for targeted cancer therapy
2019 · Byeongjun Yu, Dobeen Hwang, et al. · Cancer Research
標的化癌治療のための二重特異性ペプチド-抗体複合体に基づくハイブリッドプラットフォーム【jst・京大機械翻訳】
2019 · Yu Byeongjun, Hwang Dobeen, et al. · Angewandte Chemie International Edition
Works count: 24
Citation count: 498
H-index: 11
I10-index: 12
Year
Topic
Type